Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Multiple Myeloma × Clear all

Phase

Phase 2 34 Phase 3 27 Phase 1/2 4 Phase 1 3 Phase NA 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

OTHER 20 INDUSTRY 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Lymphoma 3 Leukemia 2 Colorectal Neoplasms 2 Xerostomia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Previously Treated Non-Small Cell Lung Cancer 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Mouth Neoplasms 1

Interventions

Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02270307 2014-10-21

MSC-CY

National Research Center for Hematology, Russia

Phase 2/3 Unknown

Other hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡